US 6287537
Radioimmunotherapy of lymphoma using anti-CD20 antibodies
expired A61KA61K2039/505A61K51/1069
Quick answer
US patent 6287537 (Radioimmunotherapy of lymphoma using anti-CD20 antibodies) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Sep 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Grant date
- Tue Sep 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 136
- CPC classes
- A61K, A61K2039/505, A61K51/1069